N

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707

Watchlist Manager
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
Watchlist
Price: 13.81 CNY 2.6% Market Closed
Updated: May 18, 2024

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Gross Profit Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
N
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
Gross Profit
¥2B
CAGR 3-Years
7%
CAGR 5-Years
20%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Gross Profit
¥9.1B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Gross Profit
¥4.9B
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
20%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Gross Profit
¥19.5B
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Gross Profit
¥10.5B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
8%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Gross Profit
¥319.6m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
2B CNY

Based on the financial report for Sep 30, 2023, Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Gross Profit amounts to 2B CNY.

What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
20%

Over the last year, the Gross Profit growth was 0%. The average annual Gross Profit growth rates for Nanjing King-friend Biochemical Pharmaceutical Co Ltd have been 7% over the past three years , 20% over the past five years .